Genflow Biosciences
Cambridge
About Genflow Biosciences
GenFlow Biosciences is a synthetic biology corporation that creates gene therapies to delay or stop the aging process in both humans and canines. It is committed to the development and promotion of creative therapies that target aging in both humans and animals. Its main goals are extending life expectancy and creating treatments that can fight off diseases that are brought on by aging and advanced age.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $12.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2026)
- Ticker: lse:GENF
- Website: genflowbio.com
- Phone: +32 477495881
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/genflow-biosciences-56380 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.